Amplifon S.p.A ROA 2019-2023 | AMFPF
Current and historical return on assets (ROA) values for Amplifon S.p.A (AMFPF) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Amplifon S.p.A ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2023-03-31 | $0.10B | $3.83B | 2.62% |
| 2022-03-31 | $0.09B | $4.02B | 2.45% |
| 2021-03-31 | $0.10B | $3.99B | 3.18% |
| 2020-03-31 | $0.09B | $3.25B | 3.87% |
| 2019-03-31 | $0.12B | $3.11B | 8.45% |
| 2018-12-31 | $0.12B | $2.62B | 18.17% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $7.290B | $2.233B |
| Amplifon SpA provides hearing solutions and services. It operates principally in Italy, France, Spain, Portugal, Switzerland, Austria, Holland, the United States, Hungary and Egypt. Amplifon SpA is based in Milan, Italy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $123.860B | 15.54 |
| Cencora (COR) | United States | $47.415B | 18.92 |
| ICON (ICLR) | Ireland | $25.281B | 24.93 |
| DiDi Global (DIDIY) | China | $23.464B | 0.00 |
| Avantor (AVTR) | United States | $17.398B | 23.97 |
| CochLear (CHEOY) | $13.726B | 0.00 | |
| Viatris (VTRS) | United States | $13.628B | 3.89 |
| Revvity (RVTY) | United States | $12.785B | 22.26 |
| Medpace Holdings (MEDP) | United States | $12.615B | 41.50 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.511B | 0.00 |
| Charles River Laboratories (CRL) | United States | $12.369B | 22.55 |
| Natera (NTRA) | United States | $10.994B | 0.00 |
| Solventum (SOLV) | United States | $10.955B | 0.00 |
| HealthEquity (HQY) | United States | $6.853B | 51.20 |
| Bausch + Lomb (BLCO) | Canada | $5.218B | 20.07 |
| Organon (OGN) | United States | $4.734B | 4.58 |
| Doximity (DOCS) | United States | $4.585B | 34.14 |
| PACS (PACS) | United States | $3.659B | 0.00 |
| Sotera Health (SHC) | United States | $3.221B | 15.81 |
| Surgery Partners (SGRY) | United States | $3.213B | 29.86 |
| Progyny (PGNY) | United States | $3.114B | 52.26 |
| Life Times (LTH) | United States | $2.882B | 31.85 |
| GoodRx Holdings (GDRX) | United States | $2.753B | 139.40 |
| Premier (PINC) | United States | $2.520B | 9.22 |
| Teladoc Health (TDOC) | United States | $2.326B | 0.00 |
| Agilon Health (AGL) | United States | $2.195B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.166B | 7.01 |
| BrightSpring Health Services (BTSG) | United States | $1.832B | 0.00 |
| Agiliti (AGTI) | United States | $1.366B | 22.31 |
| Establishment Labs Holdings (ESTA) | $1.364B | 0.00 | |
| NovoCure (NVCR) | Jersey | $1.297B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.979B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.790B | 8.17 |
| Embecta (EMBC) | United States | $0.626B | 4.14 |
| InnovAge Holding (INNV) | United States | $0.544B | 0.00 |
| Enhabit (EHAB) | United States | $0.515B | 46.68 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.511B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.506B | 0.00 |
| LifeMD (LFMD) | United States | $0.440B | 0.00 |
| CareDx (CDNA) | United States | $0.426B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.419B | 0.00 |
| Beauty Health (SKIN) | United States | $0.397B | 0.00 |
| DocGo (DCGO) | United States | $0.365B | 58.33 |
| MultiPlan (MPLN) | United States | $0.361B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.323B | 0.00 |
| ModivCare (MODV) | United States | $0.320B | 4.24 |
| GeneDx Holdings (WGS) | United States | $0.313B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.285B | 0.00 |
| Sharecare (SHCR) | United States | $0.262B | 0.00 |
| Biodesix (BDSX) | United States | $0.124B | 0.00 |
| So-Young (SY) | China | $0.123B | 41.33 |
| Oncology Institute (TOI) | United States | $0.088B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.075B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| NeueHealth (NEUE) | United States | $0.051B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.027B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| OncoCyte (OCX) | United States | $0.020B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |